Yumuk, V. (Volkan)
- Publications
- item.page.relationships.isContributorAdvisorOfPublication
- item.page.relationships.isContributorOfPublication
4 results
Search Results
Now showing 1 - 4 of 4
- Sugar-sweetened beverages and weight gain in children and adults: a systematic review from 2013 to 2015 and a comparison with previous studies(2017) Farpour-Lambert, N. (Nathalie); Winzer, E. (Eva); Bes-Rastrollo, M. (Maira); Yumuk, V. (Volkan); Luger, M. (Maria); Lafontan, M. (Max)Objective: Partly inconsistent findings from previous reviews have fueled discussions on the impact of sugar-sweetened beverages (SSBs) on obesity development. The aim was to systematically review the recent evidence in children and adults. Methods: Data were retrieved from the databases MEDLINE, EMBASE, and Cochrane library for the period January 2013 to October 2015. A systematic review of prospective cohort studies and randomized controlled trials (RCTs) relating SSBs to weight measures was conducted. Results: 30 publications met the inclusion criteria. Prospective cohort studies (96%; n = 26) showed a positive association between consumption of SSBs and weight/BMI in adults and children (n = 242,352), and only one cohort study in children showed no association. Findings from three RCTs in children demonstrated that SSB consumption had an effect on BMI/BMI z-score. The one RCT in adults showed no significant effect of the intervention. 63% of the studies were of good, 30% of medium quality, and none was funded by industry. Conclusion: Recent evidence suggests that SSB consumption is positively associated with or has an effect on obesity indices in children and adults. By combining the already published evidence with the new one, we conclude that public health policies should aim to reduce the consumption of SSBs and encourage healthy alternatives such as water. (c) 2017 The Author(s) Published by S. Karger GmbH, Freiburg
- Obesity and COVID-19: The two sides of the coin(Karger, 2020) Farpour-Lambert, N. (Nathalie); Busetto, L. (Luca); Ramos-Salas, X. (Ximena); OMalley, G. (Grace); Woodward, E. (Euan); Mullerova, D. (Dana); Hassapiou, M.N. (Maria N.); Frühbeck, G. (Gema); Yumuk, V. (Volkan); Halford, J.C.G. (Jason C. G.); Golan, R. (Rachel); Sagen, J.V. (Jorn V.); Bettini, S. (Silvia); Dicker, D. (Dror); Goossens, G.H. (Gijs H.)The World Health Organization declared COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, a pandemic on March 12, 2020. COVID-19 is causing massive health problems and economic suffering around the world. The European Association for the Study of Obesity (EASO) promptly recognised the impact that the outbreak could have on people with obesity. On one side, emerging data suggest that obesity represents a risk factor for a more serious and complicated course of COVID-19 in adults. On the other side, the health emergency caused by the outbreak diverts attention from the prevention and care of non-communicable chronic diseases to communicable diseases. This might be particularly true for obesity, a chronic and relapsing disease frequently neglected and linked to significant bias and stigmatization. The Obesity Management Task Force (OMTF) of EASO contributes in this paper to highlighting the key aspects of these two sides of the coin and suggests some specific actions.
- European association for the study of obesity position statement on the global COVID-19 pandemic(Karger, 2020) Farpour-Lambert, N. (Nathalie); Busetto, L. (Luca); Ramos-Salas, X. (Ximena); Woodward, E. (Euan); Holm, J.C. (Jens-Christian); Lehtinen-Jacks, S. (Susanna); Mullerova, D. (Dana); Frühbeck, G. (Gema); Yumuk, V. (Volkan); Halford, J.C.G. (Jason C. G.); O’Malley, G. (Grace); Handjieva-Darlenska, T. (Teodora); Rutter, H. (Harry); Sagen, J.V. (Jorn V.); Dicker, D. (Dror); Hassapidou, M. (Maria); Lyn-Baker, J. (Jennifer); Goossens, G.H. (Gijs H.)COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, was declared a pandemic by the World Health Organization on March 12, 2020. The European Association for the Study of Obesity (EASO), as a scientific and medical society dedicated to the promotion of health and well-being, is greatly concerned about this global health challenge and its significant impacts on individuals, families, communities, health systems, nations, and wider society.
- The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications(S. Karger AG, 2019) Farpour-Lambert, N. (Nathalie); Busetto, L. (Luca); Woodward, E. (Euan); Frühbeck, G. (Gema); Yumuk, V. (Volkan); Halford, J.C.G. (Jason C. G.); Hebebrand, J. (Joahnnes); Blaak, E.E. (Ellen E.); Toplak, H. (Hermann); Dicker, D. (Dror); Goossens, G.H. (Gijs H.)Obesity is a frequent, serious, complex, relapsing, and chronic disease process that represents a major public health problem. The coining of obesity as an adiposity-based chronic disease (ABCD) is of particular relevance being in line with EASO’s proposal to improve the International Classification of Diseases ICD-11 diagnostic criteria for obesity based on three dimensions, namely etiology, degree of adiposity, and health risks. The body mass index as a unique measurement of obesity does not reflect the whole complexity of the disease. Obesity complications are mainly determined by 2 pathological processes, i.e., physical forces (fat mass disease) as well as endocrine and immune responses (sick fat disease), which are embedded in a cultural and physical context leading to a specific ABCD stage.